The Korea Disease Control and Prevention Agency extends the use of the Oxford-AstraZeneca vaccine to people aged 65 and older as overseas trials show its effectiveness. (The Korea Herald) COVID-19 pandemic in South KoreaCOVID-19 pandemic in AsiaCOVID-19 pandemic link embed save